STOCK TITAN

Im Cannabis Corp Stock Price, News & Analysis

IMCC Nasdaq

Welcome to our dedicated page for Im Cannabis news (Ticker: IMCC), a resource for investors and traders seeking the latest updates and insights on Im Cannabis stock.

IM Cannabis Corp (IMCC) provides premium medical cannabis products in regulated international markets, with operational hubs in Israel and Germany. This news hub offers investors and industry stakeholders centralized access to official updates and market developments.

Track all corporate announcements including regulatory milestones, strategic partnerships, and operational expansions. Our curated collection ensures timely access to earnings reports, product launches, and compliance achievements that shape this medical cannabis leader's trajectory.

Discover updates on IMCC's EU-GMP certified operations, Focus Medical Herbs collaboration in Israel, and Adjupharm GmbH's German distribution network. Content spans supply chain innovations, licensing agreements, and quality control advancements critical to medical cannabis operations.

Bookmark this page for verified updates from a company maintaining strict adherence to international medical standards. Stay informed about IMCC's data-driven approach to cultivation and distribution in complex regulatory environments.

Rhea-AI Summary

IM Cannabis Corp. reported its financial results for Q1 2024, showing a 13% revenue increase compared to Q4 2023. Gross profit increased by 125% but dropped by 39% compared to Q1 2023. Operating expenses decreased by 29%, with a 12% increase in Non-IFRS Adjusted EBITDA loss. The Company plans a private placement of secured convertible debentures. Despite revenue effects from the Israel-Hamas war, IMC expects growth in the German market post-legalization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.45%
Tags
-
Rhea-AI Summary

IM Cannabis Corp. will report its operational and financial results for the first quarter of 2024 on May 8th, 2024. The company, a key player in the medical cannabis sector operating in Israel and Germany, will hold a zoom conference at 9:00am ET to discuss the results with investors. A recording will be available on the company's website within 24 hours.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.07%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.86%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.23%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.86%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.86%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
40.02%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.9%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.5%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
conferences earnings

FAQ

What is the current stock price of Im Cannabis (IMCC)?

The current stock price of Im Cannabis (IMCC) is $1.93 as of October 10, 2025.

What is the market cap of Im Cannabis (IMCC)?

The market cap of Im Cannabis (IMCC) is approximately 10.2M.
Im Cannabis Corp

Nasdaq:IMCC

IMCC Rankings

IMCC Stock Data

10.23M
2.90M
44.66%
4.31%
0.15%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv